Novartis AG is 167.5x more valuable than Generate Biomedicines, Inc. by market capitalization ($282.64 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GENB | NVS |
|---|---|---|
| Market cap | $1.69 B | $282.64 B |
| US-listed rank | #2229 | #47 |
| SEC filings | 47 | 947 |
Novartis AG is 167.5x more valuable than Generate Biomedicines, Inc. by market capitalization ($282.64 B vs $1.69 B).
Full pages: Generate Biomedicines, Inc. and Novartis AG, or browse the full rankings.